Ms Sheila Ann Good, LCSW | |
205 Hamner Park Rd, Carney, OK 74832-9707 | |
(580) 761-6996 | |
Not Available |
Full Name | Ms Sheila Ann Good |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 205 Hamner Park Rd, Carney, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326514977 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 29022 (Oklahoma) | Secondary |
1041C0700X | Social Worker - Clinical | 6104 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Sheila Ann Good, LCSW 205 Hamner Park Rd, Carney, OK 74832-9707 Ph: (580) 761-6996 | Ms Sheila Ann Good, LCSW 205 Hamner Park Rd, Carney, OK 74832-9707 Ph: (580) 761-6996 |
News Archive
At Plastic Surgery 2009, Axis Three (www.axisthree.com), the leader and pioneer of 3D surgical simulation tools for the cosmetic surgery industry, today introduced its Portrait 3D Face Simulation Module, the Company's latest innovation in its 3D surgical simulation technology.
A new study, led by researchers at Columbia University Medical Center, pinpoints the role that two genes - Factor H and Factor B - play in the development of nearly three out of four cases of age-related macular degeneration (AMD), a devastating eye disease that affects more than 10 million people in the United States.
A new study takes a deep look at the connection between shift work and type 2 diabetes. Investigators at Brigham and Women's Hospital leveraged data on hundreds of thousands of people in the UK Biobank to better understand how shift work - especially frequent night work - contributes to the likelihood of type 2 diabetes.
A research group at UmeƄ University in Sweden has managed to capture and describe a protein structure that, until now, has been impossible to study. The discovery lays the base for developing designed enzymes as catalysts to new chemical reactions for instance in biotechnological applications.
In the wake of recent disappointments over clinical trials targeting amyloid plaque build-up in Alzheimer's disease, researchers are focusing more attention on misfolded tau protein, another culprit in brain diseases that cause dementia.
› Verified 7 days ago